StockData
Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR) KPIs and segments

OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$27.57−2.27 (-7.61%)

Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của Oscar Health · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của Oscar Health: 51 chỉ số vận hành, trong đó có Total Effectuated Members (Period-End), Medical Loss Ratio (MLR) và Selling, General, and Administrative Expense Ratio, lấy từ 552 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Total Effectuated Members (Period-End)1
2,691,8852,963,0023,174,4892,042,4492,116,9042,027,1482,039,4671,676,9701,654,2841,580,7251,448,4081,036,283
Individual and Small Group Effectuated Members (ACA Marketplace & CHOICE / ICHRA)
2,691,8852,963,0023,174,4892,042,4492,111,7362,017,0582,021,4841,636,4001,602,9931,522,4321,386,980967,002
Medical Loss Ratio (MLR)(%)2
84.0%79.2%70.5%95.4%88.5%91.1%75.4%88.1%84.6%79.0%74.2%86.4%
Net Medical Claims Before Ceded Quota Share Reinsurance (MLR Numerator)($M)
4,2333,7943,2302,6202,5862,5532,2602,0642,0021,7131,5561,202
Net Earned Premiums Before Ceded Quota Share Reinsurance (MLR Denominator)($M)
5,0424,7894,5812,7472,9242,8032,9962,3442,3652,1672,0961,391
Selling, General, and Administrative (SG&A) Expense Ratio(%)3
14.0%14.2%15.2%18.2%17.5%18.7%15.8%19.5%19.0%19.6%18.4%25.4%
Member Acquisition and Servicing Costs (Broker Commissions, Marketing & Care Guides)($M)
337326350232247261235196196185171
Premium Taxes, ACA Exchange User Fees, and Other Regulatory Fees($M)
20218819711712111097.611611510992.4
All Other SG&A Expenses (Corporate, Technology & Administrative Overhead)($M)
183177160162153163150154150142131
Adjusted EBITDA (Non-GAAP)($M)
207415727-308-102-199329-113-11.6104219-112
Direct Policy Premiums Earned (Before ACA Risk Adjustment & Reinsurance)($M)4
5,7245,6676,0303,5533,6463,4833,3502,7502,6882,5442,3101,622
ACA Risk Adjustment Transfers Recognized in Premium Revenue($M)
-677-872-1,443-803-728-692-374-449-375-433-269-286
Reinsurance Premiums Ceded (Quota Share & Excess-of-Loss)($M)
-5.10-5-5.60-2.90-3-2.70-2.50-1.900.10-7.60-4.60-0.80
Assumed Reinsurance Premiums($M)
0.04-0.68-0.980.278.2515.622.446.455.160.557.654.6
Other Non-Premium Revenues (Marketplace Brokerage & Platform Subsidiaries)($M)
6.296.095.728.968.806.504.334.905.23
Direct Medical Claims Incurred (Gross of Reinsurance)($M)2
4,3083,8733,2942,6612,6272,5622,2682,0881,9861,6801,5241,158
Ceded Reinsurance Claims Recoveries($M)
-76.1-78.4-62.7-43.2-47.8-22.2-31-68.3-41.2-30-19.7-10.9
Assumed Reinsurance Claims Incurred($M)
0.90-0.03-1.302.057.2513.122.445.159.058.650.857.9
Net ACA Risk Adjustment Transfer Payable to CMS (Ending Balance)($M)5
2,9954,8463,9742,5321,6792,5601,8671,4941,020
Net Risk Adjustment Payable — Current Policy Year($M)
3,0502,3741,3582,5281,7189892811,4931,025
Net Risk Adjustment Payable (Receivable) — Prior Policy Years($M)
-55.72,4732,6164.20-38.81,5711,5860.90-4.60
Gross ACA Risk Adjustment Payable to CMS (Ending Balance)($M)2
3,1254,9424,0522,5881,7712,6471,9551,5581,084722279-766
Gross Risk Adjustment Payable — Current Policy Year($M)
3,0962,4021,3742,5841,7601,0223071,5571,073
Gross Risk Adjustment Payable — Prior Policy Years($M)
29.72,5402,6774.2011.81,6251,6481.1011.1
Gross ACA Risk Adjustment Receivable from CMS (Ending Balance)($M)2
13195.877.356.192.687.687.164.863.5-20.2-10.1-4.30
Gross Risk Adjustment Receivable — Current Policy Year($M)
45.52816.1564233.325.764.647.8
Gross Risk Adjustment Receivable — Prior Policy Years($M)
85.367.861.2050.654.361.50.2015.7
Net ACA Risk Adjustment Accrual Charge (Rollforward)($M)2
6778721,443802728692374439
Net Risk Adjustment Accrual — Current Policy Year($M)
6771,0161,358810729707281468
Net Risk Adjustment Accrual — Prior Policy Years Development($M)
0.80-14484.6-7.60-1.50-1592.6-29.2
Benefits & Unpaid Claims Payable — Gross Liability (Ending Balance)($M)6
1,9241,8981,7341,4551,5641,5521,4661,3571,3571,2521,248966
Reinsurance Recoverable Deducted from Benefits Payable($M)
59.162.148.426.527.819.533.358.659.15559.757.1
Benefits & Unpaid Claims Payable — Net of Reinsurance (Ending Balance)($M)
1,8901,8611,7081,4481,5571,5531,4521,3161,3161,2141,206922
Total Reinsurance Recoverable on Paid & Unpaid Claims (Asset)($M)
27119714399.8159193188292273241243241
Reinsurance Payable (Liability)($M)
1.702.605.103.607.3013.423.641.351.160.161.961
Unearned Health Insurance Premiums (Advance Member & CMS Payments)($M)
16016817216677.169.570.974.466.16065.565.9
Allowance for Credit Losses on Accounts Receivable($M)
19.155.37.177.237.287.3522.731.330.130.430.631.6
Net Medical Claims & CAE Incurred (Actuarial Reserve Rollforward)($M)2
4,2673,8243,2482,6662,5862,5652,2892,0912,0361,7361,5781,242
Incurred Claims & CAE — Related to Current Policy Year($M)
4,3103,8673,4002,6982,6302,6112,4062,1342,0541,7851,6321,241
Incurred Claims & CAE — Related to Prior Policy Years (Reserve Development)($M)
-43-43-151-32.2-43.8-45.7-118-43.4-18.1-49.4-53.81.10
Net Medical Claims & CAE Cash Paid (Actuarial Reserve Rollforward)($M)2
4,2383,6712,9882,7752,5822,4642,1532,0911,9341,7271,2951,169
Cash Claims & CAE Paid — Current Policy Year($M)
4,1383,5682,2652,7452,5052,2981,5542,0291,8841,6049251,138
Cash Claims & CAE Paid — Prior Policy Years($M)
99.910372430.576.81665996249.312337030.9
Health Insurance Subsidiaries — Total Cash, Cash Equivalents & Investments($M)5
8,6009,7007,8005,100
Health Insurance Subsidiaries — Statutory Deposits with State Regulators($M)
18.919.619.118.3
Parent & Non-Insurance Subsidiaries — Total Cash, Cash Equivalents & Investments($M)
360462279414
Parent & Non-Insurance Subsidiaries — Restricted Cash & Investments($M)
8.609.609.6014.7
Consolidated Restricted Cash, Cash Equivalents & Deposits($M)
22.624.724.13023.924.423.823.925.823.122.321.7
Noncurrent Restricted Cash & Investments on Deposit($M)
27.529.228.63327.931.13130.930.129.929.829.9
Gross Investment Income (Before Investment Management Expenses)($M)4
91.383.461.149.952.254.346.442.750.550.243.235.8
Investment Income — Fixed Maturity Debt Securities($M)
40.632.327.529.328.830.327.227.72317.114.313.8
Investment Income — Cash Equivalents & Money Market Funds($M)
50.751.033.621.723.123.718.614.026.031.427.317.3
Investment Management Expenses($M)
0.460.340.520.330.140.310.300.250.210.170.170.21
Accrued Investment Income Receivable (Ending Balance)($M)
45.346.623.120.223.421.82319.820.715.596.60
Available-for-Sale (AFS) Fixed Maturity Securities — Due 1 to 5 Years (Fair Value)($M)11
1,3271,5281,1721,3861,6481,7371,8141,8131,9341,466737365
AFS Debt Securities — Due Within 1 Year (Fair Value)($M)
3,0224,4801,9951,217888938752625504364616690
AFS Debt Securities — Due 5 to 10 Years (Fair Value)($M)
11269.690.782.810110755.90
AFS Debt Securities — Due Within 1 Year (Amortized Cost)($M)
3,0284,4821,9931,213885936750624503365617691
AFS Debt Securities — Due 1 to 5 Years (Amortized Cost)($M)
1,3591,5351,1681,3721,6351,7251,8061,8161,9091,468738363
AFS Debt Securities — Due 5 to 10 Years (Amortized Cost)($M)
11670.190.8829910655.50
AFS Securities in Unrealized Loss <12 Months (Fair Value)($M)
3,7653,3181,0413482377606428775541,2611,036559
AFS Securities in Unrealized Loss <12 Months (Gross Unrealized Loss)($M)
42.99.923.280.490.302.724.329.801.064.402.951.16
AFS Securities in Unrealized Loss <12 Months (Security Lot Count)
780605270107107243206301165490302133
AFS Securities in Unrealized Loss ≥12 Months (Fair Value)($M)
019.83040.83440047.75181.916.330.1
AFS Securities in Unrealized Loss ≥12 Months (Gross Unrealized Loss)($M)
00.310.210.121.05000.030.070.440.070.10
AFS Securities in Unrealized Loss ≥12 Months (Security Lot Count)
023583006716623
Class A Common Stock Outstanding (1 Vote per Share, Period-End)(M)4
275273264262226223218215212206201194
Class B Common Stock Outstanding (20 Votes per Share — Co-Founders / Thrive, Period-End)(M)
35.235.235.635.835.735.535.535.535.535.535.535.5
Incremental Dilutive Shares — Employee Equity Awards (RSUs, PSUs & Options)(M)
16.410.510.800018.0-1.58028.625.70
Incremental Dilutive Shares — Convertible Senior Notes (If-Converted Method)(M)
20.720.720.70036.7-36.7036.736.70
Anti-Dilutive Securities Excluded from Diluted EPS(M)
0.190.656.63-35.483.070.27.9536.678.81.559.06-4.17
Centene Corporation (CNC) — Total Consolidated Revenues($M)3
50,64753,57949,94449,72549,69048,74246,62040,80542,02339,83640,40739,460
Molina Healthcare, Inc. (MOH) — Total Consolidated Revenues($M)3
11,08210,87410,79611,37511,47711,42711,14710,49910,3409,8809,9319,048
Elevance Health, Inc. (ELV) — Total Consolidated Revenues($M)4
51,42950,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,647
The Cigna Group (CI) — Total Consolidated Revenues($M)3
73,68371,66868,49472,47269,74867,17865,50265,64963,69460,52357,25551,114
CVS Health Corporation (CVS) — Total Consolidated Revenues($M)4
108,399106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,813
UnitedHealth Group Incorporated (UNH) — Total Consolidated Revenues($M)4
112,694112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,427
Humana Inc. (HUM) — Total Consolidated Revenues($M)4
41,15540,86739,64832,51532,64932,38832,11229,21329,39729,54029,61126,462
BEA Personal Consumption Expenditures — Health Care Services (DHLCRC1Q027SBEA, SAAR)($M)
3,858,7003,790,3003,699,9003,667,0003,614,9003,529,8003,464,7003,417,8003,358,2003,288,2003,244,4003,159,400
Total Consolidated Revenue($M)6
5,1394,8804,6472,8052,9862,8643,0462,3922,4242,2192,1421,432
Premiums Earned (Net of Risk Adjustment & Ceded Reinsurance)($M)
5,0424,7894,5812,7472,9242,8032,9962,3452,3682,1642,0941,390
Net Investment Income($M)
90.883.160.650.9525446.142.450.3504335.5
Medical / Policyholder Benefits Expense($M)
4,2333,7943,2302,6202,5862,5532,2602,0652,0041,7091,5551,205
Selling, General, and Administrative Expenses($M)
722691706511522535483466460435394364
Depreciation and Amortization($M)
6.50677.907.3076.709.207.507.607.807.70
Total Operating Expenses($M)
4,9614,4923,9433,1393,1153,0942,7492,5402,4722,1521,9571,577
Earnings (Loss) from Operations($M)3
178389704-334-129-231297-148-48.467.8186-146
Interest Expense($M)
4.704.705.40-1.106.905.80665.8065.906.20
Earnings (Loss) Before Income Taxes($M)
175383699-353-139-234288-154-52.360.9179-151
Income Tax Expense (Benefit)($M)
8.1021.219.8-0.20-1.80-512.7-0.402.104.601-0.80
Net Income (Loss) Attributable to Oscar Health, Inc.($M)5
167362679-353-137-228275-154-54.656.2177-150
Consolidated Net Income (Loss) Including Noncontrolling Interests($M)
167362679-352-138-229276-153-54.456.3178-150
Earnings (Loss) per Share — Basic($)
0.541.202.28-0.53-0.891.10-0.220.240.77
Earnings (Loss) per Share — Diluted($)
0.491.102.07-0.53-0.890.92-0.220.200.62
Weighted-Average Common Shares — Basic(M)
309302298259256251243239231
Weighted-Average Common Shares — Diluted(M)
346333330259256306243304294
Total Consolidated Assets($M)6
10,00911,2279,2906,3255,7466,3845,8444,8414,4835,0064,4193,602
Cash and Cash Equivalents($M)
4,4674,0764,8052,7742,1492,5992,2371,5511,2062,2682,2311,870
Short-Term Investments($M)
3,0224,4801,9951,217888938752625504364616690
Long-Term Investments($M)
1,4421,6011,2671,4711,7511,8461,8731,8151,9341,466737365
Accounts Receivable, Net($M)
303380587363
Total Current Assets($M)
8,3169,3737,7774,6133,7634,3133,7752,8452,3683,3593,5043,061
Property, Equipment, and Capitalized Software, Net($M)
10910294.288.383.477.77266.866.66461.461.9
Total Consolidated Liabilities($M)5
7,7839,1727,6235,3454,7195,2234,5083,8243,3183,8663,3852,795
Accounts Payable and Accrued Liabilities($M)
589526506507557584634432396348303273
Total Current Liabilities($M)
7,3028,6907,1404,8633,9774,8664,1493,4632,9553,5023,0192,429
Long-Term Debt($M)
432432431430686300300300299299299299
Total Oscar Health, Inc. Stockholders' Equity($M)
2,2232,0521,6649781,0241,1581,3331,0141,1631,1381,032804
Total Stockholders' Equity (Including Noncontrolling Interests)($M)
2,2262,0551,6679811,0271,1611,3361,0161,1651,1411,034806
Net Cash Provided by (Used in) Operating Activities($M)4
-1,2012,0922,619672-965509879347-500497634297
Capital Expenditures (Property, Equipment & Capitalized Software)($M)
11.311.88.809.1099.3096.807.607.605.906.10
Stock-Based Compensation Expense($M)
22.320.71618.120.524.12525.929.328.725.926.1
Net Cash Provided by (Used in) Investing Activities($M)
1,579-2,835-590-48.7150-168-174-31.4-578-478-301173
Net Cash Provided by (Used in) Financing Activities($M)
10.913.3-3.608.2036422.14.903.8018.618.727.31.10

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Fiscal Calendar & Filing Scope: Oscar Health, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends March 31, Q2 ends June 30, Q3 ends September 30, Q4 ends December 31). Latest company filings reflected: Q3 2026 Form 10-Q and Form 8-K Item 2.02 (period ended September 30, 2026, filed November 5, 2026), June 2026 Investor Day Presentation & Fact Sheet, 2026 Definitive Proxy Statement (DEF 14A, filed April 22, 2026), FY2025 Form 10-K (filed February 13, 2026), and IPO Prospectus Form 424B4 (filed March 4, 2021). External CMS ACA Marketplace Open Enrollment Public Use Files extend through Plan Year 2026 (FY2026), and CMS Monthly Medicare Advantage / Part D enrollment extends through November 2026 (2026-11).
  • Underwriting Mechanics, ACA Risk Adjustment & Reinsurance: Oscar operates primarily in the Affordable Care Act (ACA) Individual and Small Group (including CHOICE / ICHRA) health insurance market across 18 states at year-end 2025 (expanded to 20 states in Plan Year 2026 and 21 states / 713 counties entering 2027 Open Enrollment). Direct policy premiums (91% earned via federal CMS Advanced Premium Tax Credit subsidies in Q3 2026 vs. 93% in Q3 2025) are adjusted each quarter for estimated ACA risk adjustment transfers payable to CMS ($2,994.6 million net payable as of September 30, 2026) and quota share / excess-of-loss reinsurance.
  • Single Reportable Segment & SG&A Expense Disaggregation (ASU 2023-07): Oscar manages a single reportable insurance and healthcare technology segment alongside three wholly owned individual-market brokerage and enrollment platforms acquired in 2025 (Lucie, Inc., Trove Group, Inc., and HealthInsurance.org, LLC — the 'Marketplace Subsidiaries'). Under ASU 2023-07, Oscar disaggregates consolidated SG&A into three operational buckets: Member acquisition and servicing costs, Premium taxes / exchange fees / regulatory fees, and All other corporate & technology SG&A.
  • Parent-Company Schedule I Evaluation: Oscar Health, Inc. (the parent registrant) is a holding company with $0 direct insurance underwriting premium revenue; all regulated health plans are operated by state-licensed insurance and HMO subsidiaries subject to NAIC statutory risk-based capital requirements ($1,037.8 million combined statutory capital and surplus at December 31, 2025). Accordingly, Consolidated minus Parent-Only subtraction does not apply; Group 5 reports Parent-Only Schedule I assets, cash, convertible senior notes, and capital contributions directly.
  • Data Integrity & Permitted Period Splits: Every cell displays an exact published figure from Oscar Health SEC filings or official external regulatory/statistical agencies (CMS, BLS, BEA, U.S. Census Bureau, and peer SEC XBRL filings), plus permitted standalone-quarter subtractions from cumulative year-to-date cash flow and footnote rollforward disclosures (Q2 = 6M − Q1, Q3 = 9M − 6M, and Q4 = FY − 9M, explicitly annotated on each derived cell). Approximate figures qualified by directional or rounding modifiers (such as 'approximately 2,305 employees' or 'approximately $2.3 billion' interim statutory surplus) are excluded from numeric cells.

Không hiện vì thiếu các kỳ gần đây (11)

  • Cigna+Oscar Small Group Co-Branded Membership (non-renewed after December 31, 2024; declined to 5,168 run-off members at Q3 2025 and reported as '—' / zero active plans across Q1–Q3 2026)
  • Oscar Medicare Advantage Membership (exited commercial Medicare Advantage offerings after Plan Year 2023; 1,781 members at year-end 2023 and '—' from FY2024 onward)
  • Exited State ACA Markets — California, Connecticut, Colorado, and Arkansas Year-End Membership (Oscar exited Colorado and Arkansas after 2022 and California and Connecticut after 2024, reported as '—' in FY2025 Form 10-K Item 1)
  • Legacy Pre-2024 InsuranceCo Administrative Expense Ratio, InsuranceCo Combined Ratio, Adjusted Administrative Expense Ratio, and InsuranceCo Adjusted EBITDA (retired by management beginning in FY2024 earnings releases and replaced by the consolidated SG&A Expense Ratio in Group 2)
  • Legacy +Oscar External Client Platform Membership (discontinued as a standalone KPI after realignment of external HealthOSP client contracts into single-segment operations)
  • Total Employees Headcount (disclosed only with approximate modifiers — 'approximately 2,305 employees' in FY2025 Form 10-K Item 1 and '~2,300 full-time employees' in the 2025 Impact Report)
  • Interim Quarterly Statutory Capital & Surplus Estimates (disclosed in Form 10-Q MD&A with approximate bounds such as 'estimated to be approximately $2.3 billion' at Q3 2026; exact audited year-end NAIC statutory capital and surplus is reported in Group 4)
  • CMS Federal Premium Subsidy Percentage of Direct Policy Premiums — 91% in Q3 2026 vs. 93% in Q3 2025 (newly added in Q2–Q3 2026 Form 10-Q filings without a Q1 2026 comparative percentage; documented in sheet notes)
  • Single-Period 2025 Impact Report & EEO-1 Workforce Metrics — 70% paperless billing opt-in, 85% Oswell AI question completion rate, 67% Care Guide response time reduction, and October 2024 EEO-1 headcount of 2,038 (published for a single reporting period only, lacking two consecutive annual periods)
  • CMS Medical Loss Ratio (MLR) Issuer-Level Public Use Files (latest federal CMS MLR PUF release covers Plan Year 2024, lagging FY2025; current state-level CMS Open Enrollment PUFs through Plan Year 2026 are included in Group 6)
  • Full-Year 2026 Financial Guidance & 2029 Investor Day Target Ranges — FY2026 Revenue ($19.0B–$19.3B), MLR (80.5%–81.5%), SG&A Expense Ratio (15.1%–15.6%), and Earnings from Operations ($850M–$950M) ranges, plus 2027 Open Enrollment footprint targets (forward-looking ranges rather than historical single-point actuals)

Dữ liệu cập nhật 2026-11-14.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Effectuated Membership & State Geographic Footprint (Key #1)

External Industry Peer Benchmarks (Managed Care Filings) & U.S. Healthcare Macro Indicators (FRED)

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Oscar Health

See a number that looks wrong?